Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis

Hyun-Mi Ko1, Jee-Hae Kang, Bongnam Jung

  • 1Department of Biological Sciences, College of Natural Sciences, Chonnam National University, Kwangju 500-757, Republic of Korea.

Insights

Platelet-activating factor (PAF) promotes melanoma lung metastasis by increasing matrix metalloproteinase-9 (MMP-9) expression. Inhibiting MMP-9 effectively blocks this PAF-induced metastasis, highlighting MMP-9

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Platelet-activating factor (PAF) is implicated in inflammatory and metastatic processes.
  • Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, are crucial in extracellular matrix remodeling and cancer metastasis.
  • The specific roles of MMP-2 and MMP-9 in PAF-induced pulmonary metastasis require elucidation.

Purpose of the Study:

  • To investigate the involvement of matrix metalloproteinase (MMP)-2 and MMP-9 in platelet-activating factor (PAF)-induced experimental pulmonary metastasis of B16F10 melanoma cells.
  • To determine the regulatory pathways (NF-kappaB, AP-1) controlling MMP expression in this model.
  • To assess the therapeutic potential of MMP inhibitors in preventing PAF-mediated lung metastasis.

Main Methods:

  • Murine melanoma cells (B16F10) were used in an experimental pulmonary metastasis model.
  • Platelet-activating factor (PAF) was administered to induce metastasis.
  • mRNA expression, protein levels, and enzymatic activities of MMP-2 and MMP-9 were quantified.
  • Inhibitors of NF-kappaB and AP-1 signaling pathways were employed.
  • Immunohistochemistry was used to localize MMP-9 and MMP-2 expression.
  • The effect of specific MMP-2 and MMP-9 inhibitors on B16F10 metastasis was evaluated.

Main Results:

  • PAF administration significantly increased lung mRNA, protein levels, and activity of both MMP-2 and MMP-9.
  • MMP-9 expression was notably stronger than MMP-2 and was regulated by both NF-kappaB and AP-1.
  • MMP-2 expression was regulated solely by AP-1.
  • Immunohistochemistry showed MMP-9 in bronchial epithelial cells and blood vessel walls, while MMP-2 was confined to bronchial epithelial cells.
  • PAF-induced B16F10 pulmonary metastasis was significantly inhibited by NF-kappaB and c-jun (AP-1) inhibitors.
  • A specific MMP-9 inhibitor completely abolished PAF-induced B16F10 metastasis, whereas an MMP-2 inhibitor had no effect.

Conclusions:

  • Matrix metalloproteinase-9 (MMP-9), regulated by NF-kappaB and AP-1 signaling, plays a critical role in PAF-induced enhancement of pulmonary melanoma metastasis.
  • MMP-9 is a key mediator in the process of PAF-driven melanoma cell dissemination to the lungs.
  • Targeting MMP-9 presents a potential therapeutic strategy for inhibiting PAF-mediated melanoma lung metastasis.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...